Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 22 results
Author
Title
Type
Year
Filters:
Author
is
Perner, Sven
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Perner S
,
Demichelis F
,
Beroukhim R
,
Schmidt FH
,
Mosquera J-M
,
Setlur S
,
Tchinda J
,
Tomlins SA
,
Hofer MD
,
Pienta KG
et al.
. 2006.
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
.
Cancer Res. 66(17):8337-41.
Perner S
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
,
Chinnaiyan AM
,
De Marzo AM
et al.
. 2007.
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
.
Am J Surg Pathol. 31(6):882-8.
Barry M
,
Perner S
,
Demichelis F
,
Rubin MA
. 2007.
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications.
.
Urology. 70(4):630-3.
R
Tomlins SA
,
Rhodes DR
,
Perner S
,
Dhanasekaran SM
,
Mehra R
,
Sun X-W
,
Varambally S
,
Cao X
,
Tchinda J
,
Kuefer R
et al.
. 2005.
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
.
Science. 310(5748):644-8.
P
Perner S
,
Hofer MD
,
Kim R
,
Shah RB
,
Li H
,
Möller P
,
Hautmann RE
,
Gschwend JE
,
Kuefer R
,
Rubin MA
. 2007.
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
.
Hum Pathol. 38(5):696-701.
Hofer MD
,
Kuefer R
,
Huang W
,
Li H
,
Bismar TA
,
Perner S
,
Hautmann RE
,
Sanda MG
,
Gschwend JE
,
Rubin MA
. 2006.
Prognostic factors in lymph node-positive prostate cancer.
.
Urology. 67(5):1016-21.
Mosquera J-M
,
Mehra R
,
Regan MM
,
Perner S
,
Genega EM
,
Bueti G
,
Shah RB
,
Gaston S
,
Tomlins SA
,
Wei JT
et al.
. 2009.
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.
.
Clin Cancer Res. 15(14):4706-11.
Esgueva R
,
Perner S
,
LaFargue CJ
,
Scheble V
,
Stephan C
,
Lein M
,
Fritzsche FR
,
Dietel M
,
Kristiansen G
,
Rubin MA
. 2010.
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort.
.
Mod Pathol. 23(4):539-46.
N
Pflueger D
,
Rickman DS
,
Sboner A
,
Perner S
,
Lafargue CJ
,
Svensson MA
,
Moss BJ
,
Kitabayashi N
,
Pan Y
,
de la Taille A
et al.
. 2009.
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer.
.
Neoplasia. 11(8):804-11.
M
Sboner A
,
Demichelis F
,
Calza S
,
Pawitan Y
,
Setlur SR
,
Hoshida Y
,
Perner S
,
Adami H-O
,
Fall K
,
Mucci LA
et al.
. 2010.
Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
.
BMC Med Genomics. 3:8.
Mertz KD
,
Setlur SR
,
Dhanasekaran SM
,
Demichelis F
,
Perner S
,
Tomlins S
,
Tchinda J
,
Laxman B
,
Vessella RL
,
Beroukhim R
et al.
. 2007.
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
.
Neoplasia. 9(3):200-6.
Beltran H
,
Rickman DS
,
Park K
,
Chae SSuk
,
Sboner A
,
MacDonald TY
,
Wang Y
,
Sheikh KL
,
Terry S
,
Tagawa ST
et al.
. 2011.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
.
Cancer Discov. 1(6):487-95.
I
Zhong Q
,
Rüschoff JH
,
Guo T
,
Gabrani M
,
Schüffler PJ
,
Rechsteiner M
,
Liu Y
,
Fuchs TJ
,
Rupp NJ
,
Fankhauser C
et al.
. 2016.
Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity.
.
Sci Rep. 6:24146.
G
Stark JR
,
Perner S
,
Stampfer MJ
,
Sinnott JA
,
Finn S
,
Eisenstein AS
,
Ma J
,
Fiorentino M
,
Kurth T
,
Loda M
et al.
. 2009.
Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?
J Clin Oncol. 27(21):3459-64.
Hofer MD
,
Kuefer R
,
Maier C
,
Herkommer K
,
Perner S
,
Demichelis F
,
Paiss T
,
Vogel W
,
Rubin MA
,
Hoegel J
. 2009.
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
.
Cancer Res. 69(2):640-6.
E
Setlur SR
,
Mertz KD
,
Hoshida Y
,
Demichelis F
,
Lupien M
,
Perner S
,
Sboner A
,
Pawitan Y
,
Andrén O
,
Johnson LA
et al.
. 2008.
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.
.
J Natl Cancer Inst. 100(11):815-25.
Perner S
,
Svensson MA
,
Hossain RR
,
Day JR
,
Groskopf J
,
Slaughter RC
,
Jarleborn AR
,
Hofer MD
,
Kuefer R
,
Demichelis F
et al.
. 2010.
ERG rearrangement metastasis patterns in locally advanced prostate cancer.
.
Urology. 75(4):762-7.
Rickman DS
,
Chen Y-B
,
Banerjee S
,
Pan Y
,
Yu J
,
Vuong T
,
Perner S
,
Lafargue CJ
,
Mertz KD
,
Setlur SR
et al.
. 2010.
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
.
Neoplasia. 12(12):1031-40.
Perner S
,
Wagner PL
,
Demichelis F
,
Mehra R
,
Lafargue CJ
,
Moss BJ
,
Arbogast S
,
Soltermann A
,
Weder W
,
Giordano TJ
et al.
. 2008.
EML4-ALK fusion lung cancer: a rare acquired event.
.
Neoplasia. 10(3):298-302.
D
Demichelis F
,
Setlur SR
,
Beroukhim R
,
Perner S
,
Korbel JO
,
Lafargue CJ
,
Pflueger D
,
Pina C
,
Hofer MD
,
Sboner A
et al.
. 2009.
Distinct genomic aberrations associated with ERG rearranged prostate cancer.
.
Genes Chromosomes Cancer. 48(4):366-80.
C
Mosquera JMiguel
,
Beltran H
,
Park K
,
MacDonald TY
,
Robinson BD
,
Tagawa ST
,
Perner S
,
Bismar TA
,
Erbersdobler A
,
Dhir, iv R
et al.
. 2013.
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
.
Neoplasia. 15(1):1-10.
Mosquera J-M
,
Perner S
,
Genega EM
,
Sanda M
,
Hofer MD
,
Mertz KD
,
Paris PL
,
Simko J
,
Bismar TA
,
Ayala G
et al.
. 2008.
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications.
.
Clin Cancer Res. 14(11):3380-5.